Related Experiment Video
Updated: May 15, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Fadd and Skp2 are possible downstream targets of RUNX1-EVI1
Kazuhiro Maki1, Fusako Sugita, Yuka Nakamura
1Department of Hematology and Oncology, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, Japan.
Abstract:
RUNX1-EVI1 generated by t(3;21) is a causative gene in the leukemic transformation of chronic hematopoietic stem cell tumors. Recruitment of histone deacetylase via carboxyl terminal-binding protein by RUNX1-EVI1 results in transcriptional dysregulation in target genes of wild-type RUNX1, leading to differentiation block and apoptotic prevention of myeloid precursor cells. In the present study using mouse primary hematopoietic cells, we confirmed that RUNX1-EVI1 enhances replating activity of hematopoietic colonies and represses differentiation along the myeloid lineage under treatment with granulocyte colony-stimulating factor. We then observed that these biological effects of RUX1-EVI1 are canceled by the treatment of histone deacetylase inhibitors, trichostatin A and valproic acid. To identify target genes whose expression is suppressed by RUNX1-EVI1, we compared the expression profiles of apoptosis and cell-cycle-related genes in control and RUNX1-EVI1-expressing cells, and in RUNX1-EVI1-expressing cells with and without treatment with histone deacetylase inhibitors. Notably, the expression of three genes, Fadd, Skp2 and CD40lg, was found to be suppressed in RUNX1-EVI1-expressing cells and to be recovered on treatment with histone deacetylase inhibitors. Considering that these genes have some RUNX1-binding sites, they may be direct or indirect targets of RUNX1-EVI1, and changes in their expression may play some role in leukemogenesis by RUNX1-EVI1.
Insights
The RUNX1-EVI1 fusion gene drives leukemia by blocking myeloid cell differentiation and preventing apoptosis. Histone deacetylase inhibitors reverse these effects, identifying key target genes involved in leukemogenesis.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- The RUNX1-EVI1 fusion gene, resulting from t(3;21), is implicated in the leukemic transformation of chronic hematopoietic stem cell disorders.
- RUNX1-EVI1 dysregulates target genes by recruiting histone deacetylase (HDAC) via carboxyl terminal-binding protein, inhibiting myeloid precursor cell differentiation and apoptosis.
Purpose of the Study:
- To investigate the role of RUNX1-EVI1 in myeloid cell transformation using mouse primary hematopoietic cells.
- To identify specific genes targeted by RUNX1-EVI1 that contribute to leukemogenesis.
Main Methods:
- Primary mouse hematopoietic cells were engineered to express RUNX1-EVI1.
- Cells were treated with granulocyte colony-stimulating factor (G-CSF) and/or HDAC inhibitors (trichostatin A, valproic acid).
- Gene expression profiling focused on apoptosis and cell-cycle-related genes.
Main Results:
- RUNX1-EVI1 expression enhanced replating activity and repressed myeloid differentiation under G-CSF stimulation.
- HDAC inhibitors reversed the differentiation block and apoptotic prevention induced by RUNX1-EVI1.
- Expression of Fadd, Skp2, and CD40lg was suppressed by RUNX1-EVI1 and restored by HDAC inhibitors, suggesting they are targets.
Conclusions:
- RUNX1-EVI1-mediated leukemogenesis involves HDAC recruitment and transcriptional repression of key genes like Fadd, Skp2, and CD40lg.
- HDAC inhibitors hold potential for therapeutic intervention in RUNX1-EVI1-driven leukemias.
- These identified genes may be direct or indirect targets critical for RUNX1-EVI1's oncogenic activity.
Related Concept Videos
Cis-regulatory Sequences
Master Transcription Regulators
Regulation of Expression at Multiple Steps
MAPK Signaling Cascades
TGF - β Signaling Pathway
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
